Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Zimmerman v. Diplomat Pharmacy, Inc. et al
Case Number:
2:16-cv-14005
See also:
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
Companies
Sectors & Industries:
-
April 23, 2019
Diplomat Pharmacy Inks $14M Deal In Suit Over PBM Fees
Diplomat Pharmacy has agreed to pay $14.1 million to settle a proposed class action claiming investors were kept in the dark about an increase in fees pharmacy benefits manager CVS Caremark was going to charge for Medicare Part D prescriptions.
-
November 14, 2016
Diplomat Pharmacy Faces Shareholder Suit Over Value Drop
Specialty drugmaker Diplomat Pharmacy Inc. overestimated its hepatitis C drug's financial outlook and failed to properly calculate $8 million in Medicare fees, causing share values to plummet by 42 percent once news broke, according to a lawsuit filed in Michigan federal court.